Filing Flows › Comparisons › SNWV vs IDXG
Sanuwave Health vs Interpace Biosciences: SNWV and IDXG compared
Sanuwave Health is the larger company: $9.7M of revenue in its latest quarter (Q2 2026) against $9.1M for Interpace Biosciences (Q2 2026). Interpace Biosciences is growing faster (-1% against -3% a year earlier). Interpace Biosciences is more profitable, with an operating margin of 3.5% against -2.9%.
Where the money goes: SNWV and IDXG
Sanuwave Health (SNWV) · Q2 2026
Sanuwave Health, Q2 2026: revenue $9.7M (-3% year over year), operating margin -2.9%, net loss $682K, operating cash flow $425K. The chart follows the revenue to costs, profit and cash.
Interpace Biosciences (IDXG) · Q2 2026
Interpace Biosciences, Q2 2026: revenue $9.1M (-1% year over year), operating margin 3.5%, net earnings $158K, operating cash flow $98K. The chart follows the revenue to costs, profit and cash.
| Sanuwave Health (SNWV) | Interpace Biosciences (IDXG) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $9.7M | $9.1M |
| Revenue growth, Y/Y | -3% | -1% |
| Gross margin | — | 61.9% |
| Operating margin | -2.9% | 3.5% |
| Net earnings | −$682K | $158K |
| Net margin | -7.0% | 1.7% |
| Operating cash flow | $425K | $98K |
| Free cash flow | $91K | $41K |
Where the revenue comes from
Sanuwave Health
- Consumables, parts, and accessories revenue: $7.3M (75%)
- System revenue: $2.3M (23%)
- Extended warranty: $78K (1%)
- Other: $48K (0%)
Questions
Which is bigger, Sanuwave Health or Interpace Biosciences?
Sanuwave Health is the larger company: $9.7M of revenue in its latest quarter (Q2 2026) against $9.1M for Interpace Biosciences (Q2 2026).
Is Sanuwave Health or Interpace Biosciences growing faster?
Interpace Biosciences is growing faster (-1% against -3% a year earlier).
Which is more profitable, Sanuwave Health or Interpace Biosciences?
Interpace Biosciences is more profitable, with an operating margin of 3.5% against -2.9%.
More: Sanuwave Health earnings · how Sanuwave Health makes money · Interpace Biosciences earnings · how Interpace Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.